Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – With the recent wrapping up of...
The S&P 500 Index ($SPX ) (SPY ) Monday closed up by +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.47%. Stocks...
The S&P 500 Index ($SPX ) (SPY ) today is down by -0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.92%. Stocks today are mixed,...
The S&P 500 Index ($SPX ) (SPY ) today is down by -0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.84%. Stocks today are mixed,...
The dilution monster stalked the company following the announcement of a new capital-raising effort.
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
Nuvalent announced favorable preliminary data in a clinical trial for its lung cancer drug. Here's what investors need to know.
The company reported preliminary data on a non-small cell lung cancer therapy.